US-China tech war: Who will win the global quantum computing race?

China has deployed roughly $16 billion in public funding for quantum, accounts for ~60% of global quantum patent applications and leads 66 of 74 tracked critical-technology categories, while embedding quantum in its Five-Year Plan. The U.S. ecosystem is decentralized—over 40 companies plus national labs, universities and hyperscalers—with deeper private-sector breadth; Jefferies notes one Fortune 100 firm saw ~20% performance improvement from quantum-enabled optimization. Jefferies highlights policy catalysts (potential U.S. executive orders and China’s proposed $120 billion National Venture Guidance Fund) and forecasts a commercial inflection point between 2028–2030. Implication for portfolios: meaningful sector and geopolitical tailwinds exist for selective investments over the medium term, but limited immediate market-moving impact.

Analysis

State-led scale vs. decentralized diversity creates asymmetric payoff profiles: centralized funding accelerates manufacturing scale but concentrates risk (policy reversal, misallocated capital) while a diverse private ecosystem favors combinatorial innovation across control electronics, software stacks, and classical co-processors that will be required to commercialize early quantum use-cases. The near-term commercial value is likeliest to aggregate around systems integration — racks, cryo-infrastructure, microwave control, error-correction orchestration and cloud delivery — not just qubit counts, which implies infrastructure and server OEMs will capture real cashflow before pure-play device names.

Second-order supply-chain winners include companies supplying cryogenics, high-Q materials, precision RF, and specialized interconnects; these components have long lead times and concentrated manufacturing bases, creating pricing power as pilots scale to fleets. Hyperscalers and cloud providers will act as demand multipliers: their procurement cycles and QCaaS offerings can compress adoption timelines once one or two large pilots deliver measurable TCO or performance uplift, creating discrete procurement catalysts over 6–24 months.

Tail risks are geopolitical fragmentation (export controls, onshore mandates) and classical algorithmic advances that postpone commercial quantum advantage; either can push meaningful commercialization out beyond 2030. Practical catalyst watch: national procurement programs, hyperscaler QCaaS launches, and repeatable enterprise ROI studies — these are the binary events that convert research leadership into equity returns, so prefer exposure to firms selling tangible infrastructure and integration services over speculative application-layer beneficiaries.

Key Decisions for Investors

• Buy SMCI (long stock) — sized as 1–2% portfolio position, 9–12 month horizon. Rationale: direct exposure to high-density server demand and systems integration for hybrid quantum-classical stacks. Risk/reward: target +30% if pilot-to-procurement conversion occurs within 12 months; downside -30% on AI capex slowdown or margin compression.
• LEAP call exposure on SMCI — buy 18–24 month calls (small notional, 0.5% portfolio) to capture convex upside from multi-rack orders or cloud partnerships. Rationale: asymmetric payoff if hyperscalers announce quantum-classical rack programs. Loss limited to premium paid.
• Pair trade: long SMCI / short APP — equal notional but size the short 0.6–0.8x to reflect lower conviction on APP. Timeframe 6–12 months. Rationale: overweight infrastructure capture vs. adtech whose quantum benefits are indirect and backloaded. Expected relative outperformance 15–35%; risk is an ad-recovery that lifts APP independently.
• Event-driven watchlist & alerting — trigger to add risk on (a) US national procurement order or exec action accelerating commercialization, (b) major hyperscaler QCaaS launch, or (c) a headline demonstration showing repeatable enterprise ROI. If none occur within 12 months, re-evaluate and trim hardware exposure by 25–50%.